$AXON

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

Original reporting
Published Sep 18, 2026, 8:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 10:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised — source image
Decision brief

The 30-second read

$AXONBullishHigh
01

Why it matters

The earnings beat and guidance raise provide a clear catalyst for short‑term price appreciation, while the convertible note issuance adds financing flexibility.

02

Market read

The strong earnings and capital raise are material for traders focusing on growth and defense‑related equities.

03

What to watch

Working capital needs and negative free cash flow suggest the growth may be capital intensive, warranting caution.

Relevance 9/10Novelty 9/10Timing: premarket today

Background

Axon Enterprise is a leading provider of law‑enforcement hardware and software, recently expanding its connected‑device portfolio.

Company-level read

Ticker impact

$AXONBullishHigh confidence
Context

Axon Enterprise reported Q2 FY26 revenue of $904M (+35% YoY) and raised full-year revenue guidance to 32-34% growth, while pricing $1B of 0% convertible senior notes.

Expected impact

Potential short-term rally on earnings beat, followed by modest upside as investors price in higher guidance and note proceeds.

Evidence & confidence

Revenue beat and guidance raise are material new information; the convertible note offering adds financing capacity but limited dilution risk.

Market effects

Public safety tech sector may see broader uplift as Axon's strong results highlight demand for connected devices and software solutions.

U.S. markets could benefit from the earnings beat, especially defense and law‑enforcement equipment stocks.

International and federal contracts driving growth may signal similar opportunities for peers worldwide.

Counterpoint

The note offering could signal cash burn concerns; investors may watch for dilution and margin pressure in Q3.

Key entities

  • Axon Enterprise

    Public safety technology firm reporting Q2 FY26 results.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.

$AXONMedAI 8/10

Citizens reiterates Axon Enterprise stock rating amid ALPR scrutiny

Citizens reiterated a Market Outperform rating and $700 price target for Axon Enterprise (NASDAQ: AXON), citing its ALPR technology and competitive position. Axon shares are down 17% YTD but analysts expect 33% sales growth. Q2 earnings beat expectations with $1.88 EPS on $904.3M revenue, up 35% YoY. Axon plans a $1B convertible notes offering. Needham and William Blair maintained Buy/Outperform ratings.